CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Open-market sale Chief Financial Officer sold 31,000 shares at $8.18 ($253,673)
- 4 Open-market sale Senior Vice President sold 15,711 shares at an average $13.68 ($214,954)
- 4 Open-market sale Director sold 88,000 shares at an average $15.02 ($1,321,480)
- 4 Open-market sale Chief Financial Officer sold 7,990 shares at $10.98 ($87,730)
- 4 Open-market sale Director sold 70,000 shares at an average $14.02 ($981,700)
- 4 Open-market sale Chief Executive Officer sold 195,809 shares at $14.24 ($2,788,320)
- 4 Open-market sale Senior Vice President sold 34,308 shares at an average $11.60 ($397,953)
- 4 Open-market sale Director sold 350,000 shares at $11.70 ($4,095,000)
- 4 Open-market sale Director sold 7,500 shares at $5.33 ($39,975)
- 4 Exercise or conversion Director acquired 28,000 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 35,591 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 15 · 288 filings